[go: up one dir, main page]

CN103420927A - Synthetic method of quinoxaline-2-carboxylic acid - Google Patents

Synthetic method of quinoxaline-2-carboxylic acid Download PDF

Info

Publication number
CN103420927A
CN103420927A CN2013102263914A CN201310226391A CN103420927A CN 103420927 A CN103420927 A CN 103420927A CN 2013102263914 A CN2013102263914 A CN 2013102263914A CN 201310226391 A CN201310226391 A CN 201310226391A CN 103420927 A CN103420927 A CN 103420927A
Authority
CN
China
Prior art keywords
quinoxaline
carboxylic acid
reaction
formaldehyde
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013102263914A
Other languages
Chinese (zh)
Inventor
袁宗辉
潘源虎
张西亚
周波
陶燕飞
陈冬梅
谢书宇
王旭
黄玲利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong Agricultural University
Original Assignee
Huazhong Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong Agricultural University filed Critical Huazhong Agricultural University
Priority to CN2013102263914A priority Critical patent/CN103420927A/en
Publication of CN103420927A publication Critical patent/CN103420927A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于兽药制备技术领域,具体涉及一种用于兽药残留检测的卡巴氧残留标志物喹噁啉-2-羧酸的合成方法。其制备步骤包括:1)以邻苯二胺为原料,与丙酮醛缩合,即得中间产物2-甲基喹噁啉;2)将所得中间体2-甲基喹噁啉用二氧化硒进行氧化反应,即生成喹噁啉-2-甲醛;3)将所得喹噁啉-2-甲醛用酸性高锰酸钾进一步氧化,即得目标产物喹噁啉-2-羧酸。本发明的合成方法具有反应路线设计合理、操作简单和产率较高等优点。

Figure 201310226391

The invention belongs to the technical field of preparation of veterinary drugs, and in particular relates to a method for synthesizing a carbadox residue marker quinoxaline-2-carboxylic acid used for detection of veterinary drug residues. The preparation steps include: 1) using o-phenylenediamine as raw material, condensing with aceguvaldehyde to obtain the intermediate product 2-methylquinoxaline; 2) subjecting the obtained intermediate 2-methylquinoxaline to selenium dioxide Oxidation reaction to generate quinoxaline-2-carbaldehyde; 3) further oxidation of the obtained quinoxaline-2-carbaldehyde with acidic potassium permanganate to obtain the target product quinoxaline-2-carboxylic acid. The synthesis method of the invention has the advantages of reasonable reaction route design, simple operation, high yield and the like.

Figure 201310226391

Description

一种喹噁啉-2-羧酸的合成方法A kind of synthetic method of quinoxaline-2-carboxylic acid

技术领域technical field

本发明属于兽药制备技术领域,具体涉及一种喹噁啉-2-羧酸(QCA)的化学合成方法。The invention belongs to the technical field of veterinary drug preparation, and in particular relates to a chemical synthesis method of quinoxaline-2-carboxylic acid (QCA).

背景技术Background technique

卡巴氧属于喹噁啉-1,4-二氧化物类药物,是美国辉瑞公司于二十世纪七十年代合成的广谱抗菌药。在欧盟,北美等许多国家作为抗菌促生长剂曾经广泛应用于畜、禽、水产养殖中。近年来对卡巴氧毒理学研究表明,卡巴氧及其脱一氧和脱二氧代谢物具有较强的毒性作用,主要表现为致癌、致突变作用、繁殖毒性和肝脏毒性等(

Figure BDA00003315339500011
et al,1993:Yoshimura etal,1981;Scheutwinkel-Reich et al,1984)。鉴于此,欧盟于1999年禁止卡巴氧及喹乙醇用于动物抗菌促生长,即使在美国也对卡巴氧和喹乙醇的使用做出了严格规定。我国农业部明确规定禁用兽药目录中即包括喹噁啉类药物卡巴氧。喹噁啉-2-羧酸为卡巴氧的代谢物之一,目前被规定为卡巴氧残留标识物(见JECFA第36届会议(1991))。Carbadox belongs to the class of quinoxaline-1,4-dioxide drugs and is a broad-spectrum antibacterial drug synthesized by Pfizer in the 1970s. In the European Union, North America and many other countries, it has been widely used as an antibacterial growth promoter in livestock, poultry and aquaculture. Toxicological studies on carbadox in recent years have shown that carbadox and its deoxygenated and deoxygenated metabolites have strong toxic effects, mainly manifested as carcinogenicity, mutagenicity, reproductive toxicity, and liver toxicity (
Figure BDA00003315339500011
et al, 1993: Yoshimura et al, 1981; Scheutwinkel-Reich et al, 1984). In view of this, the European Union banned carbadox and olaquindox from being used for antibacterial growth promotion in animals in 1999, and even in the United States, strict regulations have been made on the use of carbadox and olaquindox. The Ministry of Agriculture of my country clearly stipulates that the list of prohibited veterinary drugs includes the quinoxaline drug carbadox. Quinoxaline-2-carboxylic acid is one of the metabolites of carbadox, and is currently specified as a carbadoxy residue marker (see the 36th session of JECFA (1991)).

为保障食品安全,保证我国动物性食品的正常贸易往来,农业部及国家出入境检验检疫局陆续制定了动物源食品中3-甲基喹噁啉-2-羧酸和喹噁啉-2-羧酸残留检测标准(GB/T20746-2006,牛、猪的肝脏和肌肉中卡巴氧和喹乙醇及代谢物残留量的测定液相色谱-串联质谱法;农业部06年第781-3,动物源食品中3-甲基喹噁啉-2-羧酸和喹噁啉-2-羧酸残留量的测定高效液相色谱法;农业部236号公告[2003]动物源食品中卡巴氧标示残留物检测方法)。这些标准的制订为动物性食品中喹噁啉-2-羧酸的检测提供了技术支持,但是一直以来国家标准物质中心及兽药监察所没有喹噁啉-2-羧酸(QCA)标准品,而大多采用Sigma公司提供的高纯度化合物作为对照品用于残留检测,所以合成出喹噁啉-2-羧酸(QCA)并进一步制成合格的标准物质成为当务之急。In order to ensure food safety and ensure the normal trade of animal foods in China, the Ministry of Agriculture and the National Entry-Exit Inspection and Quarantine Bureau have successively formulated regulations on 3-methylquinoxaline-2-carboxylic acid and quinoxaline-2- Carboxylic acid residue detection standard (GB/T20746-2006, Determination of carbadox, olaquindox and metabolite residues in liver and muscle of cattle and pigs by liquid chromatography-tandem mass spectrometry; Ministry of Agriculture 2006 No. 781-3, Animal Determination of 3-methylquinoxaline-2-carboxylic acid and quinoxaline-2-carboxylic acid residues in source foods by high-performance liquid chromatography; Announcement No. 236 of the Ministry of Agriculture [2003] Labeling residues of carbadox in animal source foods method of detection). The formulation of these standards provides technical support for the detection of quinoxaline-2-carboxylic acid in animal foods, but there has been no standard substance of quinoxaline-2-carboxylic acid (QCA) in the National Center for Reference Materials and the Veterinary Drug Inspection Institute. Most of the high-purity compounds provided by Sigma are used as reference substances for residue detection, so it is imperative to synthesize quinoxaline-2-carboxylic acid (QCA) and further make qualified standard substances.

目前关于喹噁啉-2-羧酸合成的文献报道如下:The bibliographical information about quinoxaline-2-carboxylic acid synthesis is as follows at present:

1)美国辉瑞公司Wong,John W.等采用Pseudomonas putida(ATCC33015),生物转化2-甲基喹噁啉合成喹噁啉-2-甲酸(Wong,John W.et al.Biocatalytic oxidation of2-methylquinoxaline to 2-quinoxalinecarboxylic acid,Organic Process Research & Development,6(4),477-481;2002)。1) U.S. Pfizer Wong, John W. etc. adopt Pseudomonas putida (ATCC33015) to biotransform 2-methylquinoxaline to synthesize quinoxaline-2-carboxylic acid (Wong, John W.et al.Biocatalytic oxidation of2-methylquinoxaline to 2-quinoxalinecarboxylic acid, Organic Process Research & Development, 6(4), 477-481; 2002).

该方法采用生物发酵方法合成QCA,避免用到有毒有害化学试剂且产率较高,但是采用的菌种Pseudomonas putida(ATCC33015)来源困难价格高且培养条件苛刻,普通条件下难以实现放大生产。The method adopts a biological fermentation method to synthesize QCA, avoids the use of toxic and harmful chemical reagents, and has a high yield. However, the strain Pseudomonas putida (ATCC33015) used is difficult to source and expensive, and the cultivation conditions are harsh, so it is difficult to achieve scale-up production under ordinary conditions.

2)Harms,Arthur E.等以2-甲基喹噁啉为原料,经过与苯甲醛缩合后采用高锰酸钾氧化得到目标产物QCA(Harms,Arthur E.An Efficient Synthesis of 2-Quinoxalinecarboxylic Acid.Organic Process Research & Development,8(4),666-669;2004)。该方法通过采用高锰酸钾对中间体的碳碳双键氧化而得到羧酸,不失为一种可行的办法,但是需要用到苯甲醛缩合得到中间体2-苯乙烯喹噁啉,明显的增加了反应步骤,导致最后总产率较低。2) Harms, Arthur E. etc. used 2-methylquinoxaline as a raw material, oxidized with potassium permanganate after condensation with benzaldehyde to obtain the target product QCA (Harms, Arthur E.An Efficient Synthesis of 2-Quinoxalinecarboxylic Acid. Organic Process Research & Development, 8(4), 666-669; 2004). This method obtains carboxylic acid by adopting potassium permanganate to oxidize the carbon-carbon double bond of intermediate, may well be a feasible way, but needs to use benzaldehyde condensation to obtain intermediate 2-styrene quinoxaline, obviously increases The reaction steps were eliminated, resulting in a lower final overall yield.

3)Kepez,Mustafa等报道以2,3-二甲基喹噁啉为原料,采用二氧化硒氧化一步反应得到目标产物QCA(Kepez,Mustafa.Oxidation of 2,3-dimethylquinoxaline and2,4-dimethylquinazoline with selenium dioxide.Monatshefte fuer Chemie,120(2),127-30;1989)。该方法在二甲苯做溶剂,以二氧化硒在高温下将喹噁啉环上两个甲基氧化成羧基,同时脱羧生成目标产物QCA,方法较为简便,但是反应条件要求高且产率太低。3) Kepez, Mustafa etc. reported that 2,3-dimethylquinoxaline was used as a raw material, and the target product QCA was obtained by one-step reaction of selenium dioxide oxidation (Kepez, Mustafa.Oxidation of 2,3-dimethylquinoxaline and2,4-dimethylquinazoline with selenium dioxide. Monatshefte fuer Chemie, 120(2), 127-30; 1989). In this method, xylene is used as a solvent, and selenium dioxide is used to oxidize two methyl groups on the quinoxaline ring into carboxyl groups at high temperature, and simultaneously decarboxylate to generate the target product QCA. The method is relatively simple, but the reaction conditions are high and the yield is too low. .

发明内容Contents of the invention

本发明目的在于克服现有技术的不足,提供一种供检测卡巴氧残留检测用的标准品喹噁啉-2-羧酸的化学合成方法,该方法原料易得、操作简便。The purpose of the present invention is to overcome the deficiencies in the prior art and provide a chemical synthesis method for the standard substance quinoxaline-2-carboxylic acid used for detecting carbadoxy residues. The method has easy-to-obtain raw materials and is easy to operate.

实现本发明的总体技术路线是:Realize overall technical route of the present invention is:

本发明以邻苯二胺与丙酮醛进行缩合,即得中间产物2-甲基喹噁啉,将生成的中间体2-甲基喹噁啉再与二氧化硒进行氧化反应,即生成喹噁啉-2-甲醛;此后将得到的喹噁啉-2-甲醛用酸性高锰酸钾进一步氧化,即得目标产物喹噁啉-2-羧酸。The present invention condenses o-phenylenediamine and aceguvaldehyde to obtain the intermediate product 2-methylquinoxaline, and then oxidizes the generated intermediate 2-methylquinoxaline with selenium dioxide to generate quinoxaline Line-2-formaldehyde; Afterwards, the obtained quinoxaline-2-formaldehyde is further oxidized with acidic potassium permanganate to obtain the target product quinoxaline-2-carboxylic acid.

具体地,本发明的合成方法包括以下步骤:Specifically, the synthetic method of the present invention comprises the following steps:

1)于三口烧瓶中加入邻苯二胺,用甲醇使之溶解,加热至回流;之后按等物质的量取40%的丙酮醛,用甲醇溶液使之稀释,缓慢滴入到三口烧瓶中,回流反应16~20h,过滤;滤液经干燥后减压蒸干即得淡黄色油状物质的中间体2-甲基喹噁啉;作为优选方案,丙酮醛应稍稍过量;1) Add o-phenylenediamine in the three-necked flask, dissolve it with methanol, and heat to reflux; then take 40% aceguvaldehyde according to the amount of the same substance, dilute it with methanol solution, and slowly drop it into the three-necked flask, Reflux for 16-20 hours, filter; the filtrate is dried and evaporated to dryness under reduced pressure to obtain the intermediate 2-methylquinoxaline as a light yellow oily substance; as a preferred solution, aceglyoxal should be slightly excessive;

2)按物质的量比为1∶1.2的2-甲基喹噁啉与二氧化硒溶于乙酸乙酯或其他合适溶剂中,回流反应4~6h,过滤,滤液减压蒸干溶剂后加入适量乙酸乙酯使溶解,静置,结晶即得土黄色的中间体喹噁啉-2-甲醛;2) Dissolve 2-methylquinoxaline and selenium dioxide in ethyl acetate or other suitable solvents with a ratio of 1:1.2, reflux for 4-6 hours, filter, evaporate the filtrate to dryness under reduced pressure, and then add Proper amount of ethyl acetate to dissolve, stand still, and crystallize to obtain the khaki-yellow intermediate quinoxaline-2-carbaldehyde;

3)按物质的量比为1∶1~5∶1的喹噁啉-2-甲醛与高锰酸钾溶于吡啶中,之后加入稀硫酸,室温反应16~20h,过滤;滤液加入少量蒸馏水,蒸去大部分吡啶;之后用氢氧化钠调pH=8~9,乙酸乙酯萃取三次,弃有机相;水相冰浴,盐酸调pH=2~3,即出现大量沉淀,过滤即得固体喹噁啉-2-羧酸。3) Dissolve quinoxaline-2-carbaldehyde and potassium permanganate in pyridine with a ratio of 1:1 to 5:1, then add dilute sulfuric acid, react at room temperature for 16 to 20 hours, and filter; add a small amount of distilled water to the filtrate , evaporate most of the pyridine; then use sodium hydroxide to adjust the pH=8~9, extract with ethyl acetate three times, discard the organic phase; bathe the water phase in ice, adjust the pH=2~3 with hydrochloric acid, a large amount of precipitation will appear, filter to obtain Solid quinoxaline-2-carboxylic acid.

上述合成路线具有以下优点:The above synthetic route has the following advantages:

1、原料易得:本发明所使用的原料及试剂邻苯二胺、盐酸、高锰酸钾、氢氧化钠、甲醇、乙酸乙酯、无水硫酸镁等都是常用原料及试剂,容易得到。1. Raw materials are easy to get: the raw materials and reagents o-phenylenediamine, hydrochloric acid, potassium permanganate, sodium hydroxide, methanol, ethyl acetate, anhydrous magnesium sulfate, etc. used in the present invention are all commonly used raw materials and reagents, which are easy to obtain .

2、反应设备、操作条件等容易实现且产率稳定,适宜进一步放大生产。2. The reaction equipment and operating conditions are easy to realize and the yield is stable, which is suitable for further scale-up production.

附图说明Description of drawings

图1:是现有技术美国辉瑞公司报道的喹噁啉-2-甲酸(QCA)的生物合成路线。图中:上方的英文为菌株名称为Pseudomonas putida,括号内为菌株编号为ATCC33015,附图标记为:R:PhCH2OH,S:Glycerol 1.R:NH4Cl,R:(NH4)2SO4Fig. 1: is the biosynthetic route of quinoxaline-2-formic acid (QCA) reported by Pfizer of the prior art. In the figure: the upper English is the name of the strain Pseudomonas putida, the strain number in brackets is ATCC33015, and the reference signs are: R: PhCH 2 OH, S: Glycerol 1.R: NH 4 Cl, R: (NH 4 ) 2 SO 4 .

图2:是现有技术Harms,Arthur E.报道的喹噁啉-2-甲酸(QCA)的合成路线。Fig. 2: be prior art Harms, the synthetic route of the quinoxaline-2-formic acid (QCA) of Arthur E. report.

图3:是现有技术Kepez,Mustafa等报道的喹噁啉-2-甲酸(QCA)的合成路线。Fig. 3: is the synthetic route of quinoxaline-2-carboxylic acid (QCA) reported by prior art Kepez, Mustafa etc.

图4:是本发明的喹噁啉-2-甲酸(QCA)的合成路线。Fig. 4: is the synthetic route of quinoxaline-2-carboxylic acid (QCA) of the present invention.

图5:是本发明制备所得喹噁啉-2-羧酸的紫外扫描图谱(以甲醇为溶剂)。Fig. 5: is the ultraviolet scanning spectrum (using methanol as solvent) of the obtained quinoxaline-2-carboxylic acid prepared in the present invention.

图6:本发明制备所得喹噁啉-2-羧酸的红外图谱(KBr压片)。Fig. 6: Infrared spectrum (KBr tablet) of quinoxaline-2-carboxylic acid prepared by the present invention.

图7:本发明制备所得喹噁啉-2-羧酸的1HNMR图谱(CDCl3)。Fig. 7: 1 HNMR spectrum (CDCl 3 ) of quinoxaline-2-carboxylic acid prepared in the present invention.

图8:本发明制备所得喹噁啉-2-羧酸的质谱图(ESI,负离子模式)。Figure 8: Mass spectrum (ESI, negative ion mode) of quinoxaline-2-carboxylic acid prepared in the present invention.

具体实施方式Detailed ways

实施例1Example 1

于三口烧瓶中加入邻苯二胺10.8g,用甲醇200mL使之溶解,加热至回流;之后取40%的丙酮醛18g,用甲醇50mL使之稀释,缓慢滴入到三口烧瓶中;回流反应16~20h,过滤;无水硫酸镁干燥,过滤,蒸去甲醇,即得到淡黄色油状物质2-甲基喹噁啉12g(产率83%)。Add 10.8g of o-phenylenediamine to the three-necked flask, dissolve it with 200mL of methanol, and heat to reflux; then take 18g of 40% methylglyoxal, dilute it with 50mL of methanol, and slowly drop it into the three-necked flask; reflux reaction 16 After ~20h, filter; dry over anhydrous magnesium sulfate, filter, evaporate methanol to obtain 12 g of light yellow oily substance 2-methylquinoxaline (yield 83%).

于三口烧瓶中加入2-甲基喹噁啉10g,以乙酸乙酯为溶剂,加热至回流,之后加入二氧化硒共11g;回流反应4~6h,过滤,滤液蒸去大量乙酸乙酯,放置于4℃条件下,进行重结晶,即得土黄色的中间体喹噁啉-2-甲醛8.3g(产率76%)。Add 10g of 2-methylquinoxaline into a three-neck flask, use ethyl acetate as solvent, heat to reflux, then add selenium dioxide in total 11g; reflux reaction for 4-6h, filter, evaporate a large amount of ethyl acetate from the filtrate, place Recrystallization was carried out at 4°C to obtain 8.3 g of an earthy yellow intermediate quinoxaline-2-carbaldehyde (yield 76%).

于单口烧瓶中加入所得产物喹噁啉-2-甲醛2.2g,用吡啶20mL使之溶解;之后加入高锰酸钾0.42g和3mol·L-1的硫酸6mL,室温反应16~20h,过滤;滤液加入少量蒸馏水,蒸去大部分吡啶;之后用2mol·L-1的氢氧化钠调pH至8~9,乙酸乙酯萃取三次,弃有机相;水相冰浴,用4mol·L-1的盐酸调pH至2~3,即出现大量沉淀,过滤即得固体喹噁啉-2-羧酸1.6g(产率67%)。Add 2.2 g of the obtained product quinoxaline-2-carbaldehyde into a single-necked flask, and dissolve it with 20 mL of pyridine; then add 0.42 g of potassium permanganate and 6 mL of sulfuric acid of 3 mol L -1 , react at room temperature for 16 to 20 h, and filter; Add a small amount of distilled water to the filtrate to evaporate most of the pyridine; then adjust the pH to 8-9 with 2 mol L -1 sodium hydroxide, extract three times with ethyl acetate, discard the organic phase; hydrochloric acid to adjust the pH to 2-3, a large amount of precipitation occurred, and filtered to obtain 1.6 g of solid quinoxaline-2-carboxylic acid (67% yield).

实施例2Example 2

于三口烧瓶中加入邻苯二胺21.6g,用甲醇250mL使之溶解,加热至回流;之后取40%的丙酮醛36g,用甲醇100mL使之稀释,缓慢滴入到三口烧瓶中;回流反应16~20h,过滤;无水硫酸镁干燥,过滤,蒸去甲醇,即得到淡黄色油状物质2-甲基喹噁啉25.2g(产率88%)。Add 21.6g of o-phenylenediamine to the three-necked flask, dissolve it with 250mL of methanol, and heat to reflux; then take 36g of 40% methylglyoxal, dilute it with 100mL of methanol, and slowly drop it into the three-necked flask; reflux reaction 16 After ~20h, filter; dry over anhydrous magnesium sulfate, filter, distill methanol off to obtain 25.2 g of light yellow oily substance 2-methylquinoxaline (yield 88%).

于三口烧瓶中加入2-甲基喹噁啉20g,以1,4-二氧六环为溶剂,加热至90℃,分次加入二氧化硒共10g;搅拌反应4~6h,过滤,滤液蒸去大量溶剂,以适量乙酸乙酯溶剂后于4℃放置,结晶,即得土黄色的中间体喹噁啉-2-甲醛15.8g(产率72%)。Add 20 g of 2-methylquinoxaline to a three-necked flask, use 1,4-dioxane as a solvent, heat to 90°C, add selenium dioxide in portions to a total of 10 g; stir for 4 to 6 hours, filter, and evaporate the filtrate to A large amount of solvent was removed, and an appropriate amount of ethyl acetate was used as a solvent and placed at 4°C for crystallization to obtain 15.8 g of an earthy yellow intermediate quinoxaline-2-carbaldehyde (yield 72%).

于单口烧瓶中加入产物喹噁啉-2-甲醛5g,用吡啶20mL使之溶解;之后加入高锰酸钾0.42g和3mol·L-1的硫酸6mL,室温反应16~20h,过滤;滤液加入少量蒸馏水,蒸去大部分吡啶;之后用2mol·L-1的氢氧化钠调pH至8~9,乙酸乙酯萃取三次,弃有机相;水相冰浴,用4mol·L-1的盐酸调pH至2~3,即出现大量沉淀,过滤即得固体喹噁啉-2-羧酸3.8g(产率69%)。Add 5 g of the product quinoxaline-2-carbaldehyde into a single-necked flask, and dissolve it with 20 mL of pyridine; then add 0.42 g of potassium permanganate and 6 mL of sulfuric acid of 3 mol L -1 , react at room temperature for 16 to 20 h, and filter; add the filtrate A small amount of distilled water, evaporate most of the pyridine; then use 2mol L -1 sodium hydroxide to adjust the pH to 8-9, extract with ethyl acetate three times, discard the organic phase; water phase in ice bath, use 4mol L -1 hydrochloric acid After adjusting the pH to 2-3, a large amount of precipitates appeared, and filtered to obtain 3.8 g of solid quinoxaline-2-carboxylic acid (69% yield).

实施例3Example 3

本发明制备的产品经紫外、红外、核磁共振、质谱方法检测结果如下:The product prepared by the present invention is as follows through ultraviolet, infrared, nuclear magnetic resonance, mass spectrometry detection results:

喹噁啉-2-羧酸的紫外扫描图谱(MeOH)见图1。The UV scanning spectrum (MeOH) of quinoxaline-2-carboxylic acid is shown in Figure 1.

喹噁啉-2-羧酸的红外扫描图谱(溴化钾压片)见图2。图中:各主要吸收峰与各基团的对应关系为:3452cm-1,υOH羧羟基伸缩振动;3071cm-1,υC-H苯环C-H伸缩振动;1707cm-1,υC=O羰基伸缩振动;1498cm-1,1467cm-1苯环C=C伸缩振动。The infrared scanning spectrum (potassium bromide tablet) of quinoxaline-2-carboxylic acid is shown in Figure 2. In the figure: the corresponding relationship between each main absorption peak and each group is: 3452cm -1 , υ OH carboxyl hydroxyl stretching vibration; 3071cm -1 , υ CH benzene ring CH stretching vibration; 1707cm -1 , υ C=O carbonyl stretching vibration ; 1498cm -1 , 1467cm -1 benzene ring C=C stretching vibration.

喹噁啉-2-羧酸1HNMR谱图(Mercury400核磁共振仪,氘代三氯甲烷为溶剂)见图3。图中:7.260ppm为溶剂氘代三氯甲烷的1H的化学位移;3.180ppm为-CH3氢位移;7.826~8.155ppm为喹噁啉基团的氢位移;8.6~12.0ppm宽峰,为-COOH缔合氢键的化学位移。The 1 HNMR spectrum of quinoxaline-2-carboxylic acid (Mercury400 nuclear magnetic resonance instrument, deuterated chloroform as solvent) is shown in Figure 3. In the figure: 7.260ppm is the chemical shift of 1 H of the solvent deuterated chloroform; 3.180ppm is the hydrogen shift of -CH3 ; 7.826-8.155ppm is the hydrogen shift of the quinoxaline group; Chemical shifts of -COOH associative hydrogen bonds.

喹噁啉-2-羧酸质谱图(LC/MS-IT-TOF质谱仪)见图4(源温200℃,电子能量1.7KV,扫描质量范围125-225Da,负离子模式)。图中:m/z173.0388为喹噁啉-2-羧酸的分子离子峰;m/z129.0483为分子离子脱去CO2分子的碎片离子峰。The mass spectrum of quinoxaline-2-carboxylic acid (LC/MS-IT-TOF mass spectrometer) is shown in Figure 4 (source temperature 200°C, electron energy 1.7KV, scanning mass range 125-225Da, negative ion mode). In the figure: m/z173.0388 is the molecular ion peak of quinoxaline-2-carboxylic acid; m/z129.0483 is the fragment ion peak of the molecular ion detaching CO2 molecules.

Claims (1)

1. the synthetic method of an Oxoquinoxaline-2-carboxylic acid, it is characterized in that following steps: adopt O-Phenylene Diamine and pyruvic aldehyde to carry out obtaining intermediate product 2-Jia based quinoxaline after condensation reaction, intermediate 2-Jia based quinoxaline and the tin anhydride of generation are carried out to oxidizing reaction, De quinoxaline-2-formaldehyde, finally quinoxaline-2-formaldehyde is carried out to oxidation with potassium permanganate under acidic conditions, obtain the target product Oxoquinoxaline-2-carboxylic acid;
Synthesis step is as follows:
(1) get O-Phenylene Diamine, make it to dissolve with methyl alcohol or ethanol, then 40% the pyruvic aldehyde of measuring than 1: 1 by amount of substance, slowly splash in reaction solution, after back flow reaction 16~20h, stopped reaction, the reaction solution evaporated under reduced pressure obtains the intermediate 2-Jia based quinoxaline of faint yellow oily mater;
(2) upper step reaction product is dissolved in to solvent acetonitrile, ethyl acetate, methylene dichloride or dioxane, taking tin anhydride by 1.2 times of amount of substances adds in reaction solution, after back flow reaction 4~6h, stopped reaction, after boiling off most of solvent by reaction solution, in 4 ℃ standing, separate out khaki color crystallization Ji quinoxaline-2-formaldehyde;
(3) being dissolved in pyridine of to be 3: 1 by the amount of substance ratio measure quinoxaline-2-formaldehyde and oxidant potassium permanganate, with dilute sulphuric acid or dilute hydrochloric acid, adjust solution to acid, after at room temperature reacting 16~20h, filter, filtrate is adjusted pH to 8~9 with sodium hydroxide solution after boiling off most of pyridine, is extracted with ethyl acetate three times, discard organic phase, water intaking is adjusted to pH2~3 with dilute hydrochloric acid, separates out precipitation, filters and obtain the product Oxoquinoxaline-2-carboxylic acid.
CN2013102263914A 2013-06-07 2013-06-07 Synthetic method of quinoxaline-2-carboxylic acid Pending CN103420927A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013102263914A CN103420927A (en) 2013-06-07 2013-06-07 Synthetic method of quinoxaline-2-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013102263914A CN103420927A (en) 2013-06-07 2013-06-07 Synthetic method of quinoxaline-2-carboxylic acid

Publications (1)

Publication Number Publication Date
CN103420927A true CN103420927A (en) 2013-12-04

Family

ID=49646353

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013102263914A Pending CN103420927A (en) 2013-06-07 2013-06-07 Synthetic method of quinoxaline-2-carboxylic acid

Country Status (1)

Country Link
CN (1) CN103420927A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710371A (en) * 2013-12-13 2015-06-17 江南大学 Preparation method of trifluoromethyl-containing benzo pyrazinamide
CN105061338A (en) * 2014-11-20 2015-11-18 平原县伟峰永驻科技有限公司 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system
WO2017072039A1 (en) 2015-10-26 2017-05-04 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
CN110218195A (en) * 2018-03-02 2019-09-10 上海安谱实验科技股份有限公司 A kind of quinoxaline -2- the carboxylic acid and its synthetic method of stable isotope labeling
CN110642797A (en) * 2018-06-26 2020-01-03 上海出入境检验检疫局动植物与食品检验检疫技术中心 Synthesis method of stable isotope labeled quinoxaline-2-carboxylic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1392143A (en) * 2002-07-17 2003-01-22 常州市康瑞化工有限公司 Process for preparing 5-methyl pyrazine-2-carboxylic acid
CN101341126A (en) * 2005-10-13 2009-01-07 莫弗凯姆联合化学股份公司 Antibacterial active 5-chinolin derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1392143A (en) * 2002-07-17 2003-01-22 常州市康瑞化工有限公司 Process for preparing 5-methyl pyrazine-2-carboxylic acid
CN101341126A (en) * 2005-10-13 2009-01-07 莫弗凯姆联合化学股份公司 Antibacterial active 5-chinolin derivative

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
JOHN W. WONG 等: "Biocatalytic Oxidation of 2-Methylquinoxaline to 2-Quinoxalinecarboxylic Acid", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》, vol. 6, 31 December 2002 (2002-12-31), pages 477 - 481 *
R.K.ANDERSON 等: "THE FORMATION OF FUSED PYRROLES BY THE CONDENSATION OF HALOAZINES WITH METHYLAZINES", 《TETRAHEDRON》, vol. 35, 31 December 1979 (1979-12-31), pages 2463 - 2470 *
SHYAMAPROSAD GOSWAMI 等: "The first microwave-assisted regiospecific synthesis of6-substituted pterins", 《TETRAHEDRON LETTERS》, vol. 43, 31 December 2002 (2002-12-31), pages 8371 - 8373 *
YEWEI SUN 等: "Novel multi-functional nitrones for treatment of ischemic stroke", 《BIOORGANIC & MEDICINAL CHEMISTRY》, vol. 20, 21 April 2012 (2012-04-21), pages 3939 - 3945 *
ZONGYANG LI 等: "Combined theoretical and experimental study on the molecular structure, FT-IR,and NMR spectra of cyadox and 1,4-bisdesoxycyadox", 《JOURNAL OF MOLECULAR STRUCTURE》, 21 September 2012 (2012-09-21), pages 69 - 75, XP028973028, DOI: doi:10.1016/j.molstruc.2012.09.030 *
谷玉杰 等: "3-甲基-喹噁啉一2-羧酸的合成", 《应用化工》, vol. 39, no. 1, 31 December 2010 (2010-12-31), pages 93 - 95 *
邱银生: "喹赛多在猪体内的药动学和残留研究", 《华中农业大学博士研究生学位论文》, 31 December 2004 (2004-12-31), pages 13 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710371A (en) * 2013-12-13 2015-06-17 江南大学 Preparation method of trifluoromethyl-containing benzo pyrazinamide
CN105061338A (en) * 2014-11-20 2015-11-18 平原县伟峰永驻科技有限公司 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system
WO2017072039A1 (en) 2015-10-26 2017-05-04 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
CN110218195A (en) * 2018-03-02 2019-09-10 上海安谱实验科技股份有限公司 A kind of quinoxaline -2- the carboxylic acid and its synthetic method of stable isotope labeling
CN110218195B (en) * 2018-03-02 2022-08-09 上海安谱实验科技股份有限公司 Stable isotope labeled quinoxaline-2-carboxylic acid and synthesis method thereof
CN110642797A (en) * 2018-06-26 2020-01-03 上海出入境检验检疫局动植物与食品检验检疫技术中心 Synthesis method of stable isotope labeled quinoxaline-2-carboxylic acid

Similar Documents

Publication Publication Date Title
CN103420927A (en) Synthetic method of quinoxaline-2-carboxylic acid
CN104761549B (en) A kind of palladium ion probe and preparation thereof and application
Shoji et al. Synthesis of azulene derivatives from 2 H-cyclohepta [b] furan-2-ones as starting materials: their reactivity and properties
CN106243122B (en) A kind of fluorescence probe for detecting hydrazine and its application
Bautista et al. Palladium-catalyzed synthesis of natural and unnatural 2-, 5-, and 7-oxygenated carbazole alkaloids from N-arylcyclohexane enaminones
Čebular et al. Esterification of aryl/alkyl acids catalysed by N-bromosuccinimide under mild reaction conditions
CN108484478A (en) A kind of novel carbazoles fluorescence mercaptan labelled reagent and its synthetic method and application
Ahmed et al. Synthesis and Cytotoxic, Anti Oxidant Activites of New Chalcone Derivatives
CN103360250B (en) A kind of diacerein synthetic method of high yield
CN101648917B (en) A kind of acetylmethaquine metabolite and its preparation method and application
Di Mola et al. Scalable (Enantioselective) Syntheses of Novel 3-Methylated Analogs of Pazinaclone,(S)-PD172938 and Related Biologically Relevant Isoindolinones
Schüffler et al. Elucidation of the biosynthesis and degradation of allantofuranone by isotopic labelling and fermentation of modified precursors
CN101016267B (en) Chemical synthesis method for 3-methylquinoxaline-2-carboxylic acid
CN110759890A (en) Nopinanyl indazole silver ion fluorescent probe and preparation method thereof
CN105461726B (en) The one-step method for synthesizing of the hydroxy-porphyrin of new type water-solubility eight
CN102070540A (en) 1-oxygen-2-(1-ethoxy)-3-methyl-quinoxaline, and preparation method and application thereof
CN110964516B (en) A kind of pyrazole Schiff base fluorescent probe, its synthesis method and application
US20170121752A1 (en) Detection of acrylic acid
Ertul et al. Synthesis of novel macrocyclic lactam based receptors for alkali or transition metal cations and Cr
CN102336713B (en) A Synthetic Method of Double Labeled 2-NP-AHD-(13C,15N2)
CN101928252A (en) The preparation method of 3-methyl-2-ethanolylquinoxaline
CN110161000B (en) Hg identification method2+、Ag+Dianthracene derivative fluorescent probe and preparation method thereof
CN116606217B (en) A compound, a probe, a preparation method and an application thereof for identifying and distinguishing basic amino acids in an aqueous phase
CN115677546B (en) Chiral synthesis method of D-p-methylsulfonylphenylserine ethyl ester
Zhu et al. Synthesis and hypoglycemic activity evaluation of 7-alkoxyl-rhein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20131204